Milestone Pharmaceuticals (MIST) Return on Assets [ROA] (2019 - 2026)
Milestone Pharmaceuticals (MIST) posted Return on Assets [ROA] of -71.10% for Q3 2022, down 46.29 percentage points from -24.80% a year earlier and down 23.26 percentage points from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2021, Milestone Pharmaceuticals' Return on Assets [ROA] came in at -31.76%, up 4.79 percentage points from FY2020.
- In prior years, Milestone Pharmaceuticals' Return on Assets [ROA] was -36.55% in FY2020 (+15.67 pp) and -52.22% in FY2019.
- The Q3 2022 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2019.
- On a year-over-year basis, Return on Assets [ROA] increased in five of the last seven quarters, with an average year-over-year change of +4.34 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2021, with a gain of 38.15 percentage points; the weakest was Q3 2022, with a drop of 46.29 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Milestone Pharmaceuticals | 82.17 Mn | -88.43 Mn | 527,000.00 | -33.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.24% |
| Mar 31, 2026 | -35.33% |
| Dec 31, 2025 | -55.02% |
| Sep 30, 2025 | -74.68% |
| Jun 30, 2025 | -88.04% |
| Mar 31, 2025 | -64.98% |
| Dec 31, 2024 | -43.43% |
| Sep 30, 2024 | -41.56% |
| Jun 30, 2024 | -44.80% |
| Mar 31, 2024 | -56.43% |
| Dec 31, 2023 | -67.24% |
| Sep 30, 2023 | -60.68% |
| Jun 30, 2023 | -54.80% |
| Mar 31, 2023 | -63.88% |
| Dec 31, 2022 | -72.87% |
| Sep 30, 2022 | -70.14% |
| Jun 30, 2022 | -62.67% |
| Mar 31, 2022 | -39.31% |
| Dec 31, 2021 | -33.79% |
| Sep 30, 2021 | -24.80% |
API Access
Milestone Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();